Per Wold-Olsen

Chairman of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
2
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity May 18, 2018 – Jun 9, 2026

Per Wold-Olsen reported 56 transactions between May 18, 2018 and Jun 9, 2026. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
16.90M SEK
49 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
56
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought Oncopeptides AB shares worth 3,232,341 SEK between Feb 18, 2022 and Mar 3, 2022

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

4 insiders bought Oncopeptides AB shares worth 3,232,341 SEK between Feb 18, 2022 and Mar 3, 2022
Date Insider Transaction Shares Price Value Filing
Feb 18, 2022 Per Wold-Olsen SACQ Acquisition 100,000 9.06 SEK 905,907 SEK FI filing ↗
Feb 18, 2022 Stig Anders Jacob Lindberg SACQ Acquisition 215,000 9.28 SEK 1,996,189 SEK FI filing ↗
Feb 21, 2022 Nicolaas Bakker SACQ Acquisition 22,500 9.45 SEK 212,708 SEK FI filing ↗
Feb 24, 2022 Fredrik Lehmann SACQ Acquisition 11,700 0.11 SEK 1,287 SEK FI filing ↗
Mar 3, 2022 Nicolaas Bakker SACQ Acquisition 12,500 9.30 SEK 116,250 SEK FI filing ↗

Total of the rows above: 3,232,341 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

4 insiders bought Oncopeptides AB shares worth 2,921,367 SEK between May 26, 2021 and Jun 2, 2021

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

4 insiders bought Oncopeptides AB shares worth 2,921,367 SEK between May 26, 2021 and Jun 2, 2021
Date Insider Transaction Shares Price Value Filing
May 26, 2021 Nicolaas Bakker SACQ Acquisition 3,500 103.22 SEK 361,270 SEK FI filing ↗
May 26, 2021 Anders Martin-Löf SACQ Acquisition 2,000 102.09 SEK 204,184 SEK FI filing ↗
May 26, 2021 Per Wold-Olsen SACQ Acquisition 17,928 104.46 SEK 1,872,773 SEK FI filing ↗
May 28, 2021 Fredrik Lehmann SACQ Acquisition 2,000 100.00 SEK 200,000 SEK FI filing ↗
Jun 2, 2021 Nicolaas Bakker SACQ Acquisition 3,000 94.38 SEK 283,140 SEK FI filing ↗

Total of the rows above: 2,921,367 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

3 insiders bought Oncopeptides AB shares worth 1,020,655 SEK between Mar 17, 2021 and Mar 30, 2021

Cluster buying

3 different insiders made 3 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Oncopeptides AB shares worth 1,020,655 SEK between Mar 17, 2021 and Mar 30, 2021
Date Insider Transaction Shares Price Value Filing
Mar 17, 2021 Nicolaas Bakker SACQ Acquisition 2,500 152.91 SEK 382,275 SEK FI filing ↗
Mar 29, 2021 Anders Martin-Löf SACQ Acquisition 1,000 137.62 SEK 137,620 SEK FI filing ↗
Mar 30, 2021 Per Wold-Olsen SACQ Acquisition 3,600 139.10 SEK 500,760 SEK FI filing ↗

Total of the rows above: 1,020,655 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

5 insiders bought Oncopeptides AB shares worth 1,866,695 SEK between Sep 17, 2019 and Oct 17, 2019

Cluster buying

5 different insiders made 6 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

5 insiders bought Oncopeptides AB shares worth 1,866,695 SEK between Sep 17, 2019 and Oct 17, 2019
Date Insider Transaction Shares Price Value Filing
Sep 17, 2019 Per Wold-Olsen SACQ Acquisition 10,000 130.50 SEK 1,305,000 SEK FI filing ↗
Sep 24, 2019 Fredrik Lehmann SACQ Acquisition 33,000 0.11 SEK 3,630 SEK FI filing ↗
Sep 24, 2019 Stig Anders Jacob Lindberg SACQ Acquisition 805,500 0.11 SEK 88,605 SEK FI filing ↗
Sep 26, 2019 Anders Martin-Löf SACQ Acquisition 2,000 119.18 SEK 238,360 SEK FI filing ↗
Oct 14, 2019 Fredrik Lehmann SACQ Acquisition 2,000 113.10 SEK 226,200 SEK FI filing ↗
Oct 17, 2019 Jarl Jungnelius SACQ Acquisition 49 100.00 SEK 4,900 SEK FI filing ↗

Total of the rows above: 1,866,695 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 25 most recent rows are grouped into 15 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 56 on file in total.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Oncopeptides AB SALL Allotmentnot a buy/sell decisionreported at zero 149,743 shares 0 SEK at 0.00 SEK FI filing ↗
  2. Oncopeptides AB SSUB Subscriptionnot a buy/sell decision 418,876 shares 649.3K SEK at 1.55 SEK FI filing ↗
  3. Oncopeptides AB SALL Allotmentnot a buy/sell decisionreported at zero 254,311 shares 0 SEK at 0.00 SEK FI filing ↗
  4. Senzime AB (publ.) SACQ Acquisition 50,000 shares 313.9K SEK at 6.28 SEK FI filing ↗
  5. Oncopeptides AB SSUB Subscriptionnot a buy/sell decision 146,362 shares 468.4K SEK at 3.20 SEK FI filing ↗
  6. Oncopeptides AB SSUB Subscriptionnot a buy/sell decision 79,590 shares 254.7K SEK at 3.20 SEK FI filing ↗
  7. Senzime AB (publ.) SACQ Acquisition 150,000 shares 610.6K SEK at 4.07 SEK FI filing ↗
  8. Senzime AB (publ.) SACQ Acquisition 90,000 shares 514.0K SEK at 5.71 SEK FI filing ↗
  9. Senzime AB (publ.) SACQ Acquisition 100,000 shares 610.0K SEK at 6.10 SEK FI filing ↗
  10. Senzime AB (publ.) SACQ Acquisition 100,000 shares 614.4K SEK at 6.14 SEK FI filing ↗
  11. Senzime AB (publ.) SACQ Acquisition 26,344 shares 163.3K SEK at 6.20 SEK FI filing ↗
  12. Oncopeptides AB SALL Allotmentnot a buy/sell decisionreported at zero 108,231 shares 0 SEK at 0.00 SEK FI filing ↗
  13. Senzime AB (publ.) SACQ Acquisition 200,000 shares 90.4K SEK at 0.45 SEK FI filing ↗
  14. Oncopeptides AB SSUB Subscriptionnot a buy/sell decision 519,180 shares 1.35M SEK at 2.60 SEK FI filing ↗
  15. Oncopeptides AB SACQ Acquisition × 11 4,288 shares 116.1K SEK
    The 11 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    229 27.18 SEK 6.2K SEK FI filing ↗
    475 27.18 SEK 12.9K SEK FI filing ↗
    1,000 27.16 SEK 27.2K SEK FI filing ↗
    250 27.13 SEK 6.8K SEK FI filing ↗
    115 27.10 SEK 3.1K SEK FI filing ↗
    500 27.09 SEK 13.5K SEK FI filing ↗
    480 26.95 SEK 12.9K SEK FI filing ↗
    176 26.95 SEK 4.7K SEK FI filing ↗
    600 26.89 SEK 16.1K SEK FI filing ↗
    443 27.00 SEK 12.0K SEK FI filing ↗
    20 27.00 SEK 540 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Oncopeptides AB SE0009414576 Oncopeptides AB 901,670 — — FI marknadssok.fi.se ↗
Senzime AB (publ.) SE0002478776 Senzime AB 516,344 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Per Wold-Olsen reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.